Neuland Laboratories Limited

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 15 283
EBIT TTM (mln): 3 870
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Przychód (mln) 3,067 2,784 3,937 4,485 4,606 4,657 4,647 5,100 5,727 5,128 6,460 7,577 9,243 9,253 11,912 15,586
Przychód Δ r/r 0.0% -9.2% 41.4% 13.9% 2.7% 1.1% -0.2% 9.7% 12.3% -10.5% 26.0% 17.3% 22.0% 0.1% 28.7% 30.8%
Marża brutto 19.8% 21.8% 20.5% 27.9% 31.1% 36.7% 35.5% 38.0% 43.1% 37.6% 31.4% 36.9% 39.6% 40.2% 48.5% 32.6%
EBIT (mln) 222 138 324 330 442 550 490 650 709 290 384 736 1,096 961 2,306 4,029
EBIT Δ r/r 0.0% -37.7% 134.2% 2.0% 33.7% 24.6% -11.1% 32.8% 9.1% -59.1% 32.5% 91.4% 49.0% -12.4% 139.9% 74.7%
EBIT (%) 7.2% 5.0% 8.2% 7.4% 9.6% 11.8% 10.5% 12.7% 12.4% 5.7% 6.0% 9.7% 11.9% 10.4% 19.4% 25.8%
Koszty finansowe (mln) 0 0 0 0 0 0 183 157 145 131 99 162 118 95 131 140
EBITDA (mln) 296 262 478 479 578 700 584 734 827 493 562 1,000 1,571 1,425 2,816 4,626
EBITDA(%) 9.6% 9.4% 12.1% 10.7% 12.5% 15.0% 12.6% 14.4% 14.4% 9.6% 8.7% 13.2% 17.0% 15.4% 23.6% 29.7%
Podatek (mln) 27 -29 -3 -17 28 78 88 149 166 19 39 367 247 183 522 1,014
Zysk Netto (mln) 119 -69 53 26 139 268 159 273 328 121 164 162 806 638 1,635 3,001
Zysk netto Δ r/r 0.0% -157.9% -176.6% -51.6% 441.3% 93.4% -40.5% 71.3% 20.0% -63.2% 36.3% -1.4% 397.4% -20.8% 156.2% 83.5%
Zysk netto (%) 3.9% -2.5% 1.3% 0.6% 3.0% 5.8% 3.4% 5.4% 5.7% 2.4% 2.5% 2.1% 8.7% 6.9% 13.7% 19.3%
EPS 18.24 -10.57 8.06 4.05 17.33 33.84 18.67 30.76 42.01 10.81 13.06 12.64 62.85 49.74 127.45 233.89
EPS (rozwodnione) 18.21 -10.57 8.05 4.04 17.31 33.83 18.66 30.75 42.01 10.81 13.06 12.64 62.85 49.74 127.45 233.89
Ilośc akcji (mln) 7 7 7 6 8 8 9 9 11 11 13 13 13 13 13 13
Ważona ilośc akcji (mln) 7 7 7 6 8 8 9 9 11 11 13 13 13 13 13 13
Waluta INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR